WO1988002785A2 - Improved nucleic acid hybridization technique and kit therefor - Google Patents

Improved nucleic acid hybridization technique and kit therefor Download PDF

Info

Publication number
WO1988002785A2
WO1988002785A2 PCT/US1987/002548 US8702548W WO8802785A2 WO 1988002785 A2 WO1988002785 A2 WO 1988002785A2 US 8702548 W US8702548 W US 8702548W WO 8802785 A2 WO8802785 A2 WO 8802785A2
Authority
WO
WIPO (PCT)
Prior art keywords
probe
probes
polynucleotide
binding
solid carrier
Prior art date
Application number
PCT/US1987/002548
Other languages
English (en)
French (fr)
Other versions
WO1988002785A3 (en
Inventor
Joan Marlyn Beebe
Linda Lee Glanville
Jeffry Joseph Leary
Edward Gray Rice
Original Assignee
Beckman Instruments, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beckman Instruments, Inc. filed Critical Beckman Instruments, Inc.
Publication of WO1988002785A2 publication Critical patent/WO1988002785A2/en
Priority to FI882800A priority Critical patent/FI882800A/fi
Priority to NO882593A priority patent/NO882593D0/no
Priority to DK324088A priority patent/DK324088D0/da
Publication of WO1988002785A3 publication Critical patent/WO1988002785A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6816Hybridisation assays characterised by the detection means
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6827Hybridisation assays for detection of mutation or polymorphism
    • C12Q1/683Hybridisation assays for detection of mutation or polymorphism involving restriction enzymes, e.g. restriction fragment length polymorphism [RFLP]

Definitions

  • the present invention relates to a nucleic acid hybridization procedure, and a diagnostic kit for use with the procedure.
  • the nucleic acid may be deoxyribonucleic acid (DNA), which is usually double stranded, or ribonucleic acid (RNA), which is usually single stranded.
  • Organisms such as bacteria, fungi, viruses, yeasts, etc., can all be thus determined.
  • the identification procedure includes artificially induced lysis, whereby the cell wall of the organism is ruptured to release the nucleic acid, which can then be determined .
  • the hydrogen-bonded structure of the double helix of a nucleic acid molecule can be disrupted by heating and/or by treatment with alkali. Because there are no covalent bonds connecting the partner strands, the two polynucleotide chains of a duplex, micleic acid molecule separate entirely when all the hydrogen bonds are broken. This process of strand separation is called denatur-ation.
  • An extremely useful property of denatured nucleic acids is that, under appropriate conditions, the reaction can be reversed, so that two separated complementary strands from the same source can reform into a double helix. This is called renaturation. Renaturation involves the reaction of two complementary nucleotide sequences that were separated by denaturation.
  • This technique can also be extended to allow any complementary nucleotide sequences to anneal with each other to form a duplex structure. This is generally referred to as hybridization when nucleotide sequences from different nucleic acid moieties are involved; e.g., reaction between single-stranded DNA and RNA, or between two single- stranded DNA's from different sources.
  • Nucleic acid hybridization is a well known method for identifying specific nucleic acids. This ability of two single-stranded nucleic acid preparations to hybridize forms the basis of current nucleic acid assays. The principle of such assays is to expose two single-stranded nucleic acid preparations to each other and then to measure the amount of double-stranded material that is formed.
  • Hybridization assays usually involve the use of polynucleotide hybridization probes.
  • a probe generally comprises a single-stranded fragment of a nucleic acid, or a double-stranded fragment denatured. It is characterized by having a specific nucleotide sequence which is complementary to a corresponding nucleotide sequence on the target nucleic acid (the nucleic acid to be determined).
  • the probe and the target polynucleotide when brought together, form duplex molecules by base pairing of the complementary sequences.
  • the probe is generally prepared in purified reagent form, and a readily detectable label can be incorporated into the molecular structure of the probe. The presence of the target polynucleotide can thus be confirmed by the formation of duplex hybrid molecules carrying the label.
  • Polynucleotide hybridization probes offer inexpensive, efficient, and rapid means for detecting, localizing, and isolating "target" nucleotide sequences. Klausner et al., Biotechnology, August 1983:471-478, provide interesting background on polynucleotide hybridization probes, including a discussion of their preparation and use. Known methods for preparing polynucleotide hybridization probes and for using such probes are well documented in the literature. . See, for example. Southern, J. Mol. Biol. 98:503-517 (1975); Falkow et al., U.S. Patent No. 4,385,535; Leary et al., Proc. Natl. Acad. Sci.
  • probes typically comprise cloning a probe region into a double stranded DNA plasmid.
  • the plasmid carrying the probe region is labeled, typically by enzymatic polymerization techniques.
  • Such techniques include, for example, nick translation (Rigby et al., J. Mol. Biol.
  • probe nucleic acid can also be labeled by chemical means with haptens or biotin (Tchen et al, P.N.A.S. 81:3466 (1984), Forster et al., Nucl. Acids Res. 13:745 (1985), Viscidi et al., J. Clin. Microbiol. 23:311 (1986).
  • solution hybridization single-stranded nucleic acid preparations are mixed together in solution.
  • the reaction can be followed by the change in optical density.
  • the probe may carry a readily detectable label, such as a radioactive label.
  • the unreacted single strands are separated from the double-strands, and the double-stranded nucleic acid can be determined by detecting the presence of the label in the double stranded material.
  • HA Hydroxyapatite
  • S 1 specific enzyme
  • the degraded probe can then be separated by well known size separation techniques, such as precipitation with polyethylene glycol, chromatography, electrophoresis, and ultracentrifugation, etc.
  • Solution hybridization has the advantages of speed and reaction efficiency. However, it also has serious drawbacks.
  • the steps for separating hybridized from non- hybridized probe are generally labor intensive, time consuming, do not lend themselves to automation, and may otherwise be limiting.
  • the size separation techniques described above are relatively non-specific, inefficient, and show poor reproducibility.
  • the HA separation method is more specific, it is generally useful only if the target polynucleotide is present in large excess over the probe, or if the target is RNA, or both. Further, with unpurified samples, e.g. plant and animal tissue homogenates, blood, feces, nasal and urethral mucous, etc., effective separation can be very difficult.
  • one of the singlestranded nucleic acid preparations is immobilized by being affixed on a solid-carrier.
  • derivative forms of polynucleotides for example, one carrying a terminal aminohexyl nucleotide, can be easily attached on a variety of supports. Mosbach, K., et al., Methods in Enzymology, Vol. XLIV, 859-886, 1976.
  • Oligoribonucleotides may be immobilized on btsronate derivatives of various supports. Schott, H., et al., Biochemistry, 12, 932, 1973.
  • nitrocellulose adsorbs singlestranded DNA, but not RNA. Moreover, further adsorption o f DNA on the ni trocellulose can be prevented by well known treatments. Then if a second denatured DNA, or RNA, preparation is added, it will become affixed to the solid- carrier only if it is able to base pair with the DNA that was originally adsorbed. Usually, the nucleic acid preparation which is not originally bound to the solid- carrier is labeled. After the hybridization reaction is completed, the solid carrier is separated from the reaction mixture, and the degree of hybridization can be determined by measuring the label affixed to the solid-carrier.
  • a refinement of solid-carrier hybridization is sandwich hybridization, such as that discussed in Ranki, U.S. Patent No. 4,486,539.
  • the sample is subjected to conditions which render the target polynucleotide (the nucleic acid to be determined) single-stranded.
  • the sample is then mixed with two purified nucleic acid reagents.
  • the first nucleic acid reagent comprises a single stranded fragment of nucleic acid, having a nucleotide sequence of at least 10 bases, and being affixed to a solid-carrier.
  • the second nucleic acid reagent comprises a single stranded fragment of nucleic acid, having a nucleotide sequence of at least 10 bases, and being labeled with a radioisotope.
  • the nucleic acid reagents are capable of forming hybrid molecules by complementary base pairing with the target polynucleotide.
  • the two nucleic acid reagents are not capable of hybridizing with each other.
  • the solid carrier is then washed to substantially remove the label which is not incorporated in the hybrid molecules.
  • the presence of the target nucleic acid is then determined by measuring the label on the washed solid carrier.
  • Sandwich hybridization also provides improved specificity over methods using a single nucleic acid reagent, because it involves two specific hybridization processes.
  • An advantage of solid-carrier hybridization is the ease with which the hybrid molecule formed from the target nucleic acid and the probe(s) can be separated from the reaction mixture.
  • prior art solid-carrier hybridization techniques including the sandwich hybridization procedure of Ranki discussed above, suffer a serious drawback.
  • Kinetics dictate much slower reaction rates in solid-carrier hybridization than in solution hybridization, as not all the hybridization components are allowed to diffuse.
  • a reaction that takes minutes in solution can take hours, even days, to complete when a solid-carrier is involved.
  • the hybridization efficiency is also much lower, since some nucleic acids are unavailable for base pairing.
  • the degree of preparation required is substantial! Usually several hours are required to prepare the sample for hybridization, and one to two hours are required for washing. Relatively large amounts of probes are also required.
  • RFLP restriction fragment length polymorphization
  • test sample DNA is treated with a restriction enzyme (Mst II) which produces two different sized pieces of the globin gene for the normal and sickle alleles.
  • Mst II restriction enzyme
  • the pieces are separated by size, for example on an agarose electrophoresis gel.
  • the pieces are then rendered single-stranded, transferred to a sheet of filter paper, and the exact pieces determined in the morass of similarly-sized pieces by a hybridization probe. Both the gel electrophoresis and transfer steps of the test require the use of highly skilled personnel, and are time consuming.
  • the present invention satisfies the above needs. Specifically, it covers a method for detecting, either qualitatively or quantitatively, a single-stranded target polynucleotide in a liquid sample.
  • the method comprises the steps of:
  • each probe comprising a single- stranded polynucleotide which contains a nucleotide sequence complementary to a portion of the target polynucleotide, the probes together forming hybrid molecules by complementary base pairing with the target polynucleotide, neither probe being affixed to a solid carrier, the probes do not hybridize with each other, and the second probe having a detectable label;
  • the single-stranded target polynucleotide can be formed by denaturing a double-stranded polynucleotide.
  • the two probes bind different portions on the target polynucleotide to be determined, so that the two probes do not compete.
  • the two different portions are adjacent or close by.
  • the method of this invention is suitable for microbial diagnostics. It is also suitable for genetic disease diagnosis such as that for sickle cell anemia, and for cancer diagnosis, among other uses.
  • the method of the present invention incorporates a severing step, such as by the use of a restriction enzyme, together with a sandwich hybridization procedure.
  • the method can be used to detect a target polynucleotide in a sample which may also contain a standard polynucleotide, the nucleotide sequences of the two polynucleotide being substantially similar, the standard polynucleotide having a portion A and a portion B, the target polynucleotide having a portion A' and a portion B', the standard and target polynucleotides differing in at least one nucleotide which is located between portions A and B on the standard polynucleotide and between positions A' and B' on the target polynucleotide, the method comprising the steps of:
  • step (b) combining the treated sample from step (a) with at least two probes, being a first probe and a second probe, to form a reaction mixture, each probe comprising a single-stranded polynucleotide, the probes being unable to hybridize with each other, the first probe complementary base pairing with portion A, and with portion A', the second probe complementary base pairing with portion B, and with portion B', the two probes together forming hybrid molecules by complementary base pairing with the single-stranded segment of the target polynucleotide which contains both portions A' and B'; and
  • neither probe is affixed to a solid carrier
  • the second probe has a detectable label
  • the step for determining the persence of hybrid molecules containing both of the probes further comprising the steps of:
  • Fig. 1 is a schematic representation of the steps of the assay method of the present invention.
  • Fig. 2 is a schematic representation of a sickle cell assay using the method of the present invention.
  • Figs. 3 and 4 are plots of the relative signal of label detection vs. the target DNA concentration.
  • Fig. 5 is a plot of the binding characteristics of an avidin-cellulose solid carrier and a biotin-labelled probe.
  • a method and kit including features of the present invention can be used to detect the presence of polynucleotide (such as DNA or RNA) containing organisms, such as viruses, bacteria, fungi, yeasts, other microorganisms, and other infectious agents.
  • the method and the kit can be used, for example, in food hygiene investigations, medical diagnostic applications, and any microbial diagnostics.
  • Suitable samples include animal and plant tissue homogenates, blood, serum, feces, nasal and urethral mucous, water, dust, soil, etc. Solid samples are first slurried or homogenized in a liquid medium to form the test sample.
  • the method is also suitable for diagnosing genetic disease where normal genes have been caused to mutate.
  • the method is also suitable for cancer diagnosis.
  • a sample containing cells suspected to contain the polynucleotide to be detected (target polynucleotide) is pretreated, as necessary, to release the target polynucleotide from the cells of the organism into solution, or to render the cell wall permeable to the reagents used for detecting the target polynucleotide.
  • the target pdlynucleotide is ususally a DNA or a RNA, or derivatives or fragments thereof.
  • Hybridization takes place between single stranded polynucleotides.
  • the test sample is then subjected to conditions capable of denaturing the target polynucleotide present, e.g., heat, or heat plus high pH, such as 100 °C for 5 min., or treatment with 0.5 molar NaOH for 5 min. at 20-40°C.
  • conditions capable of denaturing the target polynucleotide e.g., heat, or heat plus high pH, such as 100 °C for 5 min., or treatment with 0.5 molar NaOH for 5 min. at 20-40°C.
  • Conditions for the denaturation of polynucleotides are well known.
  • the method of the present invention comprises a solution sandwich hybridization step and a harvesting step.
  • the test sample is combined with at least two different specific nucleotide hybridization probes to form a reaction mixture.
  • two probes can be used, being a first probe - a binding probe, and a second probe - an identification probe.
  • Each probe comprises a single-stranded polynucleotide which contains a nucleotide sequence complementary to a portion of the single-stranded target polynucleotide.
  • each probe is capable of complementary base pairing with the corresponding nucleotide sequence on the target polynucleotide.
  • the two probes bind different portions on the target polynucleotide, so that the two probes do not compete; preferably the portions are closely spaced apart (no more than about 300 nucleotides apart), more preferably the portions are immediately adjacent to each other (no more than about 10 nucleotides apart).
  • the probes are incapable of hybridizing with each other.
  • the two probes and the single-stranded target polynucleotide together hybridize to form complex double-stranded hybrid molecules.
  • neither probe is affixed to a solid carrier.
  • the second probe, the identification probe is further characterized by having a readily detectable label. The procedure is called sandwich hybridization because the target polynucleotide is "sandwiched" between the two probes in the resulting hybrid molecules.
  • the probes can be contained in separate reagents. Because the probes do not hybridize with each other, it is also possible to have all the probes in a single reagent. The order of combining the probes with the test sample is generally not important. The probes can be added to the test sample in seriatum (one after another), all at the same time, or in any other combination.
  • the reaction mixture is maintained at conditions conducive to hybridization.
  • the conditions depend on, and are generally known for, the particular polynucleotide moieties involved.
  • the hybridization is allowed to go to substantial completion. For most polynucleotides this takes no more than about one hour. For example, at a salt concentration of ab ⁇ ut 0.15 molar, a temperature of 65°C, and a plasmid probe concentration at 1.0 microgm/ml, the ' time to reach 1/2 completion is less than 20 minutes.
  • the reaction mixture is contacted with a solid carrier capable of binding the first probe (the binding probe), but not the second probe (the identification probe), and not the target polynucleotide.
  • a solid carrier capable of binding the first probe (the binding probe), but not the second probe (the identification probe), and not the target polynucleotide.
  • the terms "bind” and “binding” herein shall refer to strong binding via specific functional groups, in contrast to low level non-specific binding.
  • the hybrid molecules formed from the binding of the target polynucleotide to the two probes are thus bound on to the solid carrier via the binding probe.
  • the second probe is chosen such that there is little non-specific binding of the second probe itself on to the solid carrier.
  • the presence of the target polynucleotide in the test sample is thus confirmed by determining if any of the label is bound on the solid carrier. Quantitative determination of the amount of the target polynucleotide in the test sample is also possible, by measuring the actual amount of label bound on the solid carrier.
  • the solid carrier can be separated from the liquid phase of the reaction mixture, or it can remain mixed with the liquid phase.
  • the amount of unbound second probe in solution in the liquid phase is measured and is compared to the total amount of second probe added to the reaction mixture. A difference in the two amounts indicates that some of the second probe is bound on to the solid carrier, which in turn indicates the presence of the target polynucleotide in the sample.
  • the first probe comprises a first binding group and the solid carrier comprises a second binding group, the two binding groups binding each other by forming strong bonds with each other rapidly.
  • the two binding groups together constitute a binding pair.
  • One of the binding groups of the binding pair is linked to the base material of the solid carrier, and the other binding group is part of the first probe.
  • the binding pair can, for example, be any one of the following pairs: avidin-biotin, hapten-antibodies, antibodies-antigens, carbohydrates-lectins, riboflavin-riboflavin binding protein, metal ions-metal ion binding substances, enzyme- substrate, boronates-cis dioles, staph A proteins- antobodies, enzymes-inhibitors, etc.
  • the binding pairs also include pairs of derivatives of the above moieties.
  • the criteria for choosing the particular binding pairs include (1) the speed with which the binding groups of the pair react to bind each other, (2) the strength of the bond between the binding groups of the pair, (3) minimal interference of the binding group on the first probe with the solution sandwich hybridization step, (4) ease with which the binding groups can be linked to the base material of the solid carrier, and be used to form the first probe.
  • the base material of the solid carrier can be of a material selected from, for example, agarose, cellulose, glass, latex, polyacrylamide, polycarbonate, polyamide (e.g. Nylon TM ), polyethylene, polypropylene, polystyrene, silica gel, silica, and derivatives thereof. This list is by no means exhaustive. Any solid on which one of the binding groups of the binding pair can be affixed is suitable.
  • the solid carrier can be in various forms.
  • it can be in the form of micro-particulates with particle sizes less than 100 microns (for example, mirocrystaline cellulose), macro particulates with particle sizes of 0.1 to 2.0 mm, sheets, tubes, pipet tips, plates, filters and beads, etc.
  • Methods for affixing the second binding group to the solid carrier are well known.
  • Methods for derivatizing the polynucleotide moiety of the first probe to contain the first binding group are also also known.
  • the second probe contains a readily detectable label.
  • a readily detectable label Various methods for labeling specific polynucleotide probes are known. Any label capable of being readily detected and which does not unduly interfere with the solution hybridization step, can be used. Suitable labels include radioisotopes, light-labels, enzymes, enzyme cofactors, haptens, antibodies, avidin, biotin, carbohydrates, lectins, metal chelators, etc., and their derivatives. Detection can be direct, as with radioisotopes, or indirect, as with a hapten followed by an enzyme-labeled antibody.
  • Radioisotopes such as 3 2 p, 125 I, etc.
  • the radio-labels can be detected by well known methods such as gamma counting or scintillation counting.
  • the use of radioisotope labels can be expensive and hazardous. Detection of radioactivity generally requires expensive equipment. Special training for personnel and safety precautions are required for handling radioactive material.
  • radioisotopes have finite half-lifes; and thus the labeled polynucleotide probe usually has a relatively short shelf life (usually in the order of weeks).
  • light-labels can be chemiluminesce ⁇ t, bioluminescent, fluorescent, or phosphorescent, and under the proper conditions can provide sensitivities comparable to that of-radioisotopes.
  • the light-label can be attached to any point on the single- stranded polynucleotide segments of the probe; however, terminal positions are known to be more desirable.
  • light-labels are as follows: (1) chemiluminescent: peroxidase and functionalized iron porphyrin derivatives, (2) bioluminescent: bacterial luciferase, firefly luciferase, flavin mononucleotide (FMN), adenosine triphosphate (ATP), reduced nicotinamide adenine dinucleotide (NADH), reduced nicotinamide adenine dinucleotide phosphate (NADPH), and various long chain aldehydes (decyl aldehyde, etc.); (3) fluorescent: fluorescent nucleotides such as adenosine nucleotides, etheno-cytidine nucleotides, etc., or functionalized nucleotides (amino-hexane adenosine nucleotides, murcurinucleotides, etc.), which can first be fl uorescently labelled, and then
  • Means for attaching the light labels to the probe are well documented in the art.
  • the label is measured by exciting the label and then measuring the light response with photo-detection devices.
  • Fluorescent or phosphorescent labels can be excited by irradiation with light of the appropriate wavelength.
  • Chemiluminescent or bioluminescent labels can be chemically excited, by methods well known in the art.
  • the identification probe can also be labeled with an enzyme.
  • the hybridization product is detected by the action of the enzyme on a substrate for the enzyme.
  • an enzyme capable of acting on a chromogenic substrate can be selected.
  • the conversion ratio of the substrate can be monitored by optical analysis. The ratio is then correlated with the presence or absence of the target polynucleotide.
  • the avidin and biotin can be used to link an enzyme to a specific nucleic acid probe.
  • suitable enzymes include, for example, beta-galactosidase, alkaline phosphatase, horseradish peroxidase, and luciferase.
  • first and second probes each be complementary to substantially mutually exclusive portions of the target polynucleotide.
  • first and second probes should not compete for the same base sequence to the extent that sandwich hybridization is prevented.
  • the probes can be made from appropriate restriction endonuclease treated polynucleotide from the organism of interest, or from double-stranded polynucleotides by enzymatic methods such as Exo III digestion or RNA polymerase transcription. In these cases the probes are RNA or DNA fragments. In other cases where the base sequence of a unique portion is known, the probes can be synthesized by organic synthetic techniques (Stawinski, J. et al., Nuc. Acids Res. 4, 353, 1977; Gough, G. R. et al., Nuc. Acids Res. 6, 1557, 1979; Gough, G. R. et al., Nuc. Acids Res. 7, 1955, 1979; Narang, S.
  • the size of the probes can be from 10. nucleotides to 100,000 nucleotides in length. Below 10 nucleotides, hybridized systems are not stable and will begin to denature above 20 degrees C. A complementary polynucleotide sequence of 12 is about the minimum length required for appropriate binding specificity. The generally used minimum in practice is about 15. Above 100;000 nucleotides, hybridization (renaturation) becomes a much slower and incomplete process, see Molecular Genetics, Stent, G. S. and R. Calender, pp. 213-219, 1971. It is not necessary that the entire probe be complementary to the target polynucleotide on a base by base scale.
  • the probes should be from about 15 to about 50,000 nucleotides long, more preferably from about 15 to about 10,000 nucleotides long.
  • the number of complementary (base pairing) nucleotides on the probe is preferably between about 200 to about 5,000.
  • the complementary nucleotides are adjacent to each other, especially when the number of complementary nucleotides is low (below 200). But one-to-one complementation of all of the base pairing nucleotides on the target and the probe is not necessary. Smaller probes (15-100) lend themselves to production by automated organic synthetic techniques. Probes sized from 100-10,000 nucleotides can be obtained from appropriate enzymatic methods, or by recombinant DNA methods.
  • the labeling of smaller polynucleotide segments with the relatively bulky labeling moieties may in some cases interfere with the hybridization process. Therefore the proper choice of labels is important.
  • Some of the criteria for choosing the labels are: ease of incorporating the label into the polynucleotide without inhibiting hybridization, ease and sensitivity of detection of the label, low nonspecific binding of the labeled probe to the solid carrier, and high stability.
  • the proper hybridization conditions in the solution hybridization step are determined by the nature of the first binding group on the first probe (the binding probe), and of the label attached to the second probe (the identification probe), the size of the two probes, the [G] + [C] (guanine plus cytosine) content of the probes and the complementary nucleotide sequences on the target polynucleotide, and how the test sample is prepared.
  • the label can affect the temperature and salt concentration used for carrying out the hybridization reaction. For example, chemiluminescent catalysts can be sensitive to temperatures and salt concentrations that absorber/emitter moieties can tolerate.
  • the size of the probes affect the temperature and time for the hybridization reaction.
  • hybridizations involving reagent polynucleotide sequences in the range of 10,000 to 100,000 nucleotides may require from 40 to 80 minutes to occur at 67 degrees C, while hybridizations involving 14 to 100 nucleotides require from 5 to 30 minutes at 25 degrees C.
  • sequences with high [G] + [C] content will hybridize at higher temperatures than polynucleotide sequences with a low [G] + [C] content.
  • conditions used to prepare the test sample and to maintain the target polynucleotide in the single-stranded form can affect the temperature, time, and salt concentration used in the hybridization reaction.
  • the conditions for preparing the test sample are affected by the polynucleotide length required and the [G] + [C] content. In general, the longer the sequence or the higher the [G] + [C] content, the higher the temperature and/or lower the salt concentration required for denaturation.
  • the concentration of probe or target in the mixture also determines the time necessary for hybridization to occur. The higher the probe or target concentration the shorter the hybridization incubation time needed.
  • the basic rate of hybridization is also affected by the type of salt present in the incubation mix, its concentration, and the temperature of incubation. Sodium chloride, sodium phosphate and sodium citrate are the salts most frequently used for hybridization and the salt concentration used can be as high as 1.5 - 2M.
  • Addition of other reagents in the hybridization reaction may also increase the reaction rate, for example dextran sulfate (Wahl et al., P.N.A.S. 76:3683 (1979), polyethylene glycol (Amasirro, Anal. Biochem. 152:304 (1986)) and phenol (Kohne et al., Biochemistry 16:5329 (1977)).
  • a kit suitable for use to detect a single stranded target polynucleotide in a test sample by the assay method of the present invention can comprise a liquid polynucleotide reagent or reagents comprising at least two different probes, being a first probe - a binding probe, and a second probe - an identification probe.
  • Each probe comprises a single-stranded polynucleotide which contains a nucleotide sequence complementary to a portion of the target polynucleotide.
  • Neither probe is affixed to a solid carrier. The probes cannot hybridize with each other.
  • the second probe has a detectable label.
  • the kit also comprises a solid carrier capable of binding the first probe, but not the second probe and not the target polynucleotide.
  • the other characteristics of the probes and of the solid carrier are generally as described above in the description of the method of the present invention.
  • the kit can also further comprise means for qualitative and/or quantitative determination of the label.
  • one or more of the following components be included as part of the kit: (a) detergents capable of solubilizing the various moieties, such as sodium dodecyl sulfate, or sodium lauryl sarcosinate; (b) proteases, such as proteinases K and pronase; (c) reagents to facilitate the denaturing of the target polynucleotide, including salts and solvents; (d) reagents used in detecting the label on the second probe.
  • the components of (a), (b), (c) and the probe reagent can also be combined into a sisngle reagent or a number of reagents, as needed.
  • the above method and kit can be adapted for use for testing a series of target polynucleotides.
  • a separate set of probes is provided for each target polynucleotide, each set being specific for the particular target polynucleotide.
  • Each set of probes comprises at least two different probes, being the binding and identification probes (the first and second probes), as characterized before.
  • the solid carrier used has a binding group capable of binding the binding groups on each of the binding probes specific for the plurality of target polynucleotides, but not any of the identification probes, and not any of the target polynucleotides. Therefore a single universal solid carrier can be used with all of the different binding probes.
  • each set of probes is contained in a separate liquid reagent.
  • the above method and kit can also be adapted for simultaneous testing of several target polynucleotides in a test sample.
  • a separate set of probes is provided for each target polynucleotide, each set being specific for the corresponding polynucleotide. All the probes are incapable of hybridizing with each other.
  • Each set of probes consists of at least two different probes, being a first probe (a binding probe) and a second probe (an identification probe), the probes being as characterized previously. All the first probes carry an identical binding group, so that the first probes can all be harvested on the same solid carrier.
  • the solid carrier does not bind any of the indentification probes, and not any of the target polynucleotides.
  • the second probes comprise different labels, each label corresponding to a particular target polynucleotide. After the harvesting step, detection of the respective labels on the solid carrier yields information about the presence and/or quantities of the corresponding target polynucleotide in the sample.
  • the kit preferably all of the probes are contained in a single liquid reagent.
  • the advantages of the assay method and kit of the present invention are many.
  • the method gives the reaction speed and reaction efficiency of solution hybridization, and the ease of separation of the hybridization products from the test sample of solid carrier hybridization.
  • the assay method is highly specific, as it requires complementation of at least two probes with the target polynucleotide.
  • the solution sandwich hybridization step can be completed generally in less than an hour, and the harvesting step takes no longer than about 5 minutes (optimally less than about 0.5 minutes). Thus substantial time savings can be obtained.
  • the kit of the present invention is simple to use.
  • the user need only stock one single solid carrier reagent, which can be used for assaying all target polynucleotides. Only one liquid .reagent is required for each target polynucleotide. A third reagent for detecting the label may be required in some applications.
  • Another significant advantage of the method of the subject invention is that no extensive preparation of the test samples is necessary.
  • Prior art solution hybridization methods detect target nucleic acids which have been purified away from other cell components. Nucleic acids in cells and viruses are normally tightly complexed with other cell components, usually protein, and, in this form are not available for hybridization. Simply breaking the cell or virus open to release the contents does not necessarily render the polynucleotides available for hybridization. The polynucleotides remain complexed to other cell or viral components even though released from the cell, and may in fact become extensively degraded by nucleases which also may be released.
  • a probe added to such a mix may become complexed to "sticky" cell or viral components and be rendered unavailable for hybridization, or the probe may be degraded by nuclease action.
  • the assay technique of the subject invention can be used with unpurified samples, thus obviating the need for laborious and time-consuming purification steps.
  • the assay lends itself readily to automation which could further simplify the user's task.
  • the assay results can be either qualitative or quantitative.
  • Another aspect of the method and test kit of the subject invention is directed to genetic disease diagnosis and cancer diagnosis.
  • Ge n e t i c disease is the result of mutations in a polynucleotide's nucleotide sequence. Such mutation is also a factor in the development of cancer. Therefore, as a consequence or such genetic disease or cancer, a sample taken from the patient, and containing a normal polynucleotide (standard polynucleotide), can also contain an abnormal polynucleotide (target polynucleotide) which is a variant of the normal polynucleotide. The sample may also contain only the abnormal polynucleotide.
  • the normal and abnormal polynucleotides typically have substantially identical nucleotide sequences, except at points of mutation on the polynucleotides.
  • the normal and abnormal polynucleotides thus react differently to certain reagents.
  • the method of the present invention can be used to detect such difference between the normal and abnormal polynucleotides.
  • the method combines a severing step with a solution sandwich hybridization procedure.
  • the severing step comprises a segmenting step, and may also comprise a denaturing step if the target polynucleotide is double stranded. The order of these two steps is not significant.
  • Restriction reagents e.g., restriction enzymes
  • a restriction enzyme can, under the proper conditions, be used in a segmenting step to divide a polynucleotide at very specific sites on the nucleotide backbone.
  • the standard and target polynucleotides are substantially similar.
  • the standard polynucleotide has a portion A and a portion B.
  • the target polynucleotide has a portion A' and a portion B'.
  • the two polynucleotides differ by at least one nucleotide which is located between the polynucleotides' respective portions A and B, and A' and B'.
  • the restriction reagent is chosen such that it segments the standard polynucleotide into segments none of which contains both portions A and B; the restriction reagent segments the target polynucleotide into segments at least one of which contains both portions A' and B'.
  • the target polynucleotide is a genetic variant of the standard polynucleotide, portions A and A', and portions B and B', are identical.
  • the target and standard polynucleotides present, or their segments (from the segment step), are denatured, i.e. rendered single-stranded, if necessary, either before or after the segmenting step.
  • the treated sample thus contains single-stranded versions of the target and/or standard polynucleotides present, ready for hybridization.
  • the treated sample is then combined with at least two probes to form a reaction mixture.
  • the two probes are a first probe and a second probe.
  • Each probe comprises a singlestranded polynucleotide.
  • the probes do not hybridize with each other.
  • the first probe complementary base pairs with portion A on the. standard polynucleotide, and with portion A' on the target polynucleotide.
  • the second probe complementary base pairs with portion B on the standard polynucleotide, and with portion B' on the target polynucleotide.
  • the two probes together form hybrid molecules by base pairing with the single-stranded segment(s) of the target polynucleotide which contains both portions A' and B'.
  • portion A and portion B are on separate segments after sequentation, no hybrid molecules incorporating both the first and second probes will form.
  • the probes are attached to separate segments. Hybrid molecules having both the first and second probes will form only if the abnormal (target) polynucleotide is present in the sample.
  • the presence in the reaction mixture of hybrid molecules incorporating both of the probes would indicate the presence of the target polynucleotide in the sample.
  • the determination of the hybrid molecules formed by this sandwich hybridization procedure can be performed using previously known methods. For example, a system similar to that disclosed in Ranki, U.S. Patent No. 4,486,539, wherein one of the probes is already immobilized on a solid carrier, can be used. That is, not all of the probes need to be in solution. Other methods are also known. Alternatively, solution sandwich hybridization, followed by a harvesting step, as previously discussed can also be used.
  • neither probe is affixed to a solid carrier, and the second probe has a detectable label.
  • the reaction mixture is contacted with a solid carrier which binds the first probe, but not the second probe, and not any of the segments containing only portion B or only portion B'.
  • a subsequent determination is made to see if any of the label is bound on the solidcarrier, as previously discussed.
  • the following method is suitable for sickle cell assays.
  • a test sample suspected to contain the mutated gene DNA strands e.g. in sickle alleles
  • a restriction enzyme e.g. Ms t II.
  • Such enzymes have been used in gene mapping, in order to detect structural gene deletions in the DNA strands.
  • Direct identification of mutant genes in DNA e.g. hemoglobinopathies due to point mutation in the DNA, was also possible by virtue of the specificity of such restriction enzymes.
  • a single nucleotide change in an enzyme's cleavage site can readily be detected if the appropriate enzyme is used.
  • the restriction enzyme Mst II cleaves DNA on the average to produce fragments of 1.1 and 1.3 kb from ⁇ N and ⁇ 5 genes, respectively. Mst II cleaves a sequence (CCTNAGG) that is a subset of Ddel sites (CTNAG). The DNA from the sickle cell gene has a nucleotide variation at the Mst II site. Therefore, the mutated DNA strand will not be cleaved at that site by the Mst II enzyme. The restriction enzyme treated test sample is then subject to conditions which renders the polynucleotides single stranded.
  • a single target polynucleotide-single sample hybridization assay procedure as previously described for detecting the presence of a target polynucleotide would then be carried out, with the additional limitation that the first and second probes bind sites on the DNA strand which are oh opposite sides of the Mst II site involved in the mutation.
  • the only way that a complex hybrid molecule, comprising the target polynucleotide and both of the probes, will form, is if the gene is a mutated one - e.g. a sickle cell.
  • the normal gene is cleaved between the binding sites for the two probes.
  • the schematic of this sickle cell assay is represented in Fig. 2. This method eliminates the prior art assay steps of gel electrophoresis and transfer to solid support (filter paper). The simplification is very substantial. This assay procedure would apply equally well to the diagnosis of other genetic diseases in which gene mutations are involved.
  • the cancer diagnostic aspect would take the form of a quantitative test for the levels of messenger RNA from an oncogene, although tests similar to the sickle cell example would also be useful.
  • This example correlates the harvested signal to the target DNA concentration.
  • the target polynucleotide is mpB1017;
  • probe 1 is pHBC6 having biotin as the first binding group;
  • probe 2 is M13 10W labeled with 32 p;
  • the solid carrier is avidin-cellulose, which binds biotin on the first probe.
  • SSC 0.15 molar sodium chloride and 0.015 molar sodium citrate. SSC is used at various concentrations, "10X SSC” would be, for example, 1.5 molar sodium chloride, and 0.15 molar sodium citrate.
  • EDTA is ethylenediamine tetra-acetate
  • SDS is sodium dodecyl sulfate
  • DNA is deoxribopolynucleotide
  • BSA bovine serum albumin
  • tris:HCL tris-hydroxymethylaminomethane adjusted to the appropriate pH with hydrochloric acid.
  • Plasmid DNAs were obtained by growing transformed E. coli, strain LE392, followed by lysis of the cells with lysozyme, SDS and NaOH. DNA was further purified by centrif ugation in CsCl in the presense of ethidium bromide See Mauiatis, T., Fritsch, E. F., and Sambrook, J., 1982. Molecular cloning: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, U.S.A. Replicative form (RF) DNA from M13 bacteriophage, strain 10w was obtained in an identical fashion by growing infected E. coli strain 71.18.
  • Single-stranded virion DNA from M13 clone mpB1017 was obtained from virions in the growth media of infected E. coli 71.18 by precipitation with polyethylene glycol, centrifugation in CsCl, and extraction of the purified virus with SDS, phenol, and chloroform. Salmon, testes DNA was obtained from Sigma Chemical Company, St. Louis, MO (USA).
  • Double-stranded DNAs were labeled by nick- translation (Rigby, et al., J. Mol. Biol., 113:237, 1977) essentially as described by Leary et al., Proc. Nat'l. Acad. Sci. [USA] 80:4045, 1983.
  • Plasmid pHBC6 contains 5,400 base pairs of the human beta-globin gene, cloned in the plasmid pBR322 (Fukumaki et al., Cell 28:58.5, 1982).
  • M13 clone mpB1017 contains 1310 bases of the human globin gene, homologous to 1310 bases from the plasmid pHBC6.
  • M13 strain 10w contains 7,500 bases of bacteriophage genes, homologous to the same number of bases in clone mpB1017.
  • the regions in mpB1017 DNA that are homologous to pHBC6 and M13 10w are not overlapping.
  • the solid phase for harvesting the solution- sandwich product was prepared by activation of microcrystalline cellulose with N,N'-carbonyldiimidazole, followed by coupling to the protein avidin, using methods similar to those of Paul et al., J. Org. Chem. 27:2094, 1962.
  • the coupling ratio was 1 gram of activated cellulose to 1 mg of avidin.
  • a 1:1 slurry of the prepared solid phase of avidin:cellulose contains about 1 gm of cellulose in 6 ml of buffer.
  • Solution hybridizations were preformed in a final solution containing 5X SSC, 0.02% (w/v) each of polyvinylpyrolidone-40, ficoll-400, and BSA, as well as 25 mM NaPO 4 buffer, pH 6.5, and 250 microg./ml sonicated salmon testes DNA. All DNAs (probe 1, probe 2, target, and carrier salmon testes) were denatured at 100 degrees C for 3 to 5 minutes prior to starting the hybridization reaction.
  • PROCEDURE The following assay was done to examine the feasibility of the assay of; the present invention, and to determine the range of target DNA concentration in which the assay would be effective.
  • Plasmid pHBC6 was labeled with the ligand biotin by nick-translation with biotin-11- deoxyuridine triphosphate (Bethesda Research Laboratories, Gaithersburg, MD, USA). This constitutes probe 1 of the assay.
  • the replicative form DNA of bacteriophage M13 10w was labeled with a radioactive reporter, 32 P, by nick- translation with alpha- 32 P-deoxycytidine triphosphate (Amersham, Chicago, IL, USA). This constitutes probe 2 of the assay.
  • the target DNA was M13 mpB1017, and samples containing a range of amounts of target DNA from 20 picogra ms to 1.0 microgram were teste d. All as says conta ined 100 ng of probe 1 ( b iot in) and 50 ng o f probe 2
  • Probe and sample DNAs were mixed together in a solution of 10 mM tris:HCl, pH7.5, 1.0 mM EDTA, heat denatured, and adjusted to the solution hybridization conditions given in the methods above and incubated in a total volume of 0.2 ml overnight at 68 degrees C. This incubation time is excessive, and was used only for convenience and to assure completeness of the reaction.
  • Control assays contained probe 1 or probe 2 and 20 ng. of target, or probe 1 & probe 2 without target.
  • the separation of the product sandwich from unhybridized probes was accomplished by adding 0.2 ml of a 1:1 slurry of avidin:cellulose to the reactions, incubating at 22 degrees C for 30 min., and filtering the cellulose onto a 13 mm glass fiber filter.
  • One wash of the reaction vessel with 0.1 ml. of tris:HCl, pH 7.5, 1 mM ED-TA was also filtered on the same filter as the primary reaction.
  • the filtered solid support was further washed 2 times with 2X SSC and 0.1% (v/v) SDS, 2 times with 0.2X SSC and 0.1% SDS, and 2 times with 0.1X SSC and 0.1% SDS. The last two washes were performed at 50 degrees C, all others at room temperature.
  • the assay as performed in this example has a peak of harvested signal (probe 2) at about 30 ng of target DNA, at amounts above this level, the harvested signal decreases in a logarithmic fashion. Below 30 ng of target DNA, the assay is limited by background binding of probe 2 to the solid support and the specific radioactivity of the probe, but increases exponentially from about 0.5 ng to 10 ng of target.
  • the non-linear nature of the signal as a function of the target amount is graphically depicted in Figure 3.
  • Fig. 4 is an expanded version of Fig. 3 around the peaked signal.
  • the non-linear relationship may be a function of the nicktranslation reaction used to label the probes, since probes labeled in this fashion are known to show some elements of cooperative binding (Meinkoth and Wahl, Anal. Biochem. 138:267, 1984).
  • This example demonstrates the binding characteristics of an avidin-cellulose solid carrier and a biotin-labeled probe.
  • the kinetics and specificity of harvesting a biotin-labeled probe by binding it out of a hybridization buffer onto avidin-cellulose were examined using DNA's labeled with both biotin-11-dUTP and 3 H-dATP or labeled with 3 H-dATP alone (control).
  • the DNA was plasmid pHBC-6 labeled by nick-translation (Rigby et al., J. Md. Biol., 113:237 (1977)).
  • Avidin-cellulose (0.05 ml packed volume) suspended in 0.2 ml of 10mM Tris:HCl plus 1.0 mM EDTA (pH 7.5) was placed in each of 30 microcentrifuge tubes.
  • a mixture (0.2 ml) containing 100 nanogm. of the biotin-labeled or control DNA, 50 microgm. of carrier salmon testes DNA, 20 microgm. of yeast RNA, 0.02% (w/v) each of bovine serum albumin, ficoll, and polyvinylpryolidone in 0.075 M sodium citrate, 0.75 M sodium chloride, and 0.025 M sodium phosphate (pH 6.5) was added to the appropriate tubes.
  • the tubes containing the solid phase and hybridization mixture were incubated at room temperature on a rocking platform for times ranging from 1 min. to 300 min. After the incubation, the solid phase was collected by filtration on a teflon membrane filter. The fraction of DNA bound was determined by subtracting the radioactivity in the filtrate and washes from the total radioactivity added to each sample. The dat a are presented in Figure 5. Within 30 minutes, approximately 92% of the biotin-labeled DNA became bound to the avidincellulose, while an average of less than 2% of the control DNA bound to the solid carrier. The binding is rapid, efficient, and specific for the biotin label on the probe.
  • the requirement for the avidin component of the solid phase for binding to biotin-labeled DNA was examined using the same DNA's as above, with various pretreatments of the solid carrier. Free biotin should compete with biotin-DNA for the avidin sites on the solid phase, and pretreatment of the solid phase with 20 times the half-capacity of free biotin reduced biotin-DNA binding by 50%. A further pretreatment with 10 fold more free biotin reduced biotin-DNA binding by an additional 30%.
  • This example demonstrates the construction of M13 vectors containing Mst II fragments bordering the sicklecell mutation.
  • This Eco R1, Hd III ended 200 base pair fragment was then inserted into M13 mp 18 to obtain single-stranded DNA. Additional constructions were made using this 200 base fragment to allow simple production of large quantities of specific RNA sequences. Specifically, this fragment was inserted into the transcription vector pT7-1 and pT7-2 (United States Biochemical Corporation, P.O. Box 22406, Cleveland, Ohio, 44122). These constructions allow for the in vitro synthesis of labelled RNA to use as a probe in the sickle- cell assay of the present invention. The other recombinant vectors needed for assay of the sickle-cell trait use the 800 base pair Mst II - Hpa 1 fragment located immediately upstream of the diagnostic Mst II restriction site.
  • This fragment was cloned in a similar fashion again using Klenow DNA Polymerase to "round-off" the 5' overhanging ends found at the Mst II end.
  • This 800 base pair fragment was inserted into four vectors in order to obtain single stranded RNA and DNA. They are:
  • PT7-1-800 RNA which is non-message like pT7-2-800 RNA which is message-like
  • Priority Country US (European patent), NL (European patent), N (European patent).
  • a method for detecting a polynucleotide in a sample comprising: combining in liquid phase the sample with a and second probe, each binding to different sequences of the target polynucleotide.
  • the "target/probe" complex is im ilized subsequently with a solid carrier able to bind the first probe.
  • the second probe carries a detectable label.
PCT/US1987/002548 1986-10-14 1987-10-06 Improved nucleic acid hybridization technique and kit therefor WO1988002785A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FI882800A FI882800A (fi) 1986-10-14 1988-06-13 Foerbaettrad nukleinsyrahybridiseringsteknik och testfoerpackning.
NO882593A NO882593D0 (no) 1986-10-14 1988-06-13 Forbedret nykleinsyrehybridiseringsteknikk og kit til dette.
DK324088A DK324088D0 (da) 1986-10-14 1988-06-14 Fremgangsmaade til detektering af polynucleotider og kit til anvendelse herved

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91920186A 1986-10-14 1986-10-14
US919,201 1986-10-14

Publications (2)

Publication Number Publication Date
WO1988002785A2 true WO1988002785A2 (en) 1988-04-21
WO1988002785A3 WO1988002785A3 (en) 1988-07-14

Family

ID=25441695

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1987/002548 WO1988002785A2 (en) 1986-10-14 1987-10-06 Improved nucleic acid hybridization technique and kit therefor

Country Status (7)

Country Link
JP (1) JPH01501339A (no)
AU (1) AU8103687A (no)
CA (1) CA1309932C (no)
DK (1) DK324088D0 (no)
FI (1) FI882800A (no)
NO (1) NO882593D0 (no)
WO (1) WO1988002785A2 (no)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0322311A2 (en) * 1987-12-21 1989-06-28 Applied Biosystems, Inc. Method and kit for detecting a nucleic acid sequence
GB2225112A (en) * 1988-11-22 1990-05-23 Ici Plc Hybridisation probes
US5354657A (en) * 1988-01-12 1994-10-11 Boehringer Mannheim Gmbh Process for the highly specific detection of nucleic acids in solid
WO2001075157A1 (fr) * 2000-03-31 2001-10-11 Sanko Junyaku Co., Ltd. Sonde servant a fabriquer un polymere sonde, procede de fabrication d'un polymere sonde et son utilisation
WO2005071401A2 (en) * 2004-01-15 2005-08-04 Chiron Corporation Homogeneous multiplex assay for nucleic acid targets
US8742101B2 (en) 2003-07-25 2014-06-03 Idenix Pharmaceuticals, Inc. Purine nucleoside analogues for treating flaviviridae including hepatitis C
EP2829614A1 (en) * 2012-03-21 2015-01-28 Olympus Corporation Method for detecting target nucleic acid molecule
US9354176B2 (en) 2011-08-11 2016-05-31 Olympus Corporation Method for detecting a target particle
US9428796B2 (en) 2012-02-22 2016-08-30 Olympus Corporation Method for detecting a target particle
US9841418B2 (en) 2011-08-30 2017-12-12 Olympus Corporation Method for detecting target particle

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU593151B2 (en) * 1986-11-12 1990-02-01 Molecular Diagnostics, Inc. Method for the detection of nucleic acid hybrids
JP2897959B2 (ja) * 1988-05-20 1999-05-31 エフ.ホフマン―ラ ロシュ アクチェンゲゼルシャフト 固定化された配列特異的プローブ

Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1980002076A1 (en) * 1979-03-19 1980-10-02 Diagnostic Techn Int Inc Double tagged immunoassay
EP0094603A1 (en) * 1982-05-14 1983-11-23 American Hoechst Corporation Enzyme/immunofluorescent assay for autoantibodies
EP0130515A2 (en) * 1983-07-05 1985-01-09 Molecular Diagnostics, Inc. Testing DNA samples for particular nucleotide sequences
EP0139489A2 (en) * 1983-09-26 1985-05-02 Ortho Diagnostic Systems Inc. Sandwich hybridization method for nucleic acid detection
WO1986003227A1 (en) * 1984-11-23 1986-06-05 Dgi, Inc. An assay for nucleic acid sequences, particularly genetic lesions
WO1986003782A1 (en) * 1984-12-19 1986-07-03 Blair Malcolm A D Improved sandwich hybridisation technique for the detection of nucleotide sequences
EP0192168A2 (en) * 1985-02-22 1986-08-27 Molecular Diagnostics, Inc. Solution-phase dual hybridization assay for detecting polynucleotide sequences
EP0198662A1 (en) * 1985-04-12 1986-10-22 AMERSHAM INTERNATIONAL plc Method for nucleic acid hybridisation
EP0198622A1 (en) * 1985-04-01 1986-10-22 Ecc International Limited Paper coating apparatus and method
WO1986007387A1 (en) * 1985-06-13 1986-12-18 Amgen Method and kit for performing nucleic acid hybridization assays
EP0238332A2 (en) * 1986-03-19 1987-09-23 Cetus Corporation Liquid hybridization method and kit for detecting the presence of nucleic acid sequences in samples
EP0238353A2 (en) * 1986-03-21 1987-09-23 ARS Holding 89 N.V. Methods of immunoassay
EP0159719B1 (en) * 1984-04-27 1993-06-30 Enzo Biochem, Inc. Hybridization method for the detection of genetic materials

Patent Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1980002076A1 (en) * 1979-03-19 1980-10-02 Diagnostic Techn Int Inc Double tagged immunoassay
EP0094603A1 (en) * 1982-05-14 1983-11-23 American Hoechst Corporation Enzyme/immunofluorescent assay for autoantibodies
EP0130515A2 (en) * 1983-07-05 1985-01-09 Molecular Diagnostics, Inc. Testing DNA samples for particular nucleotide sequences
EP0139489A2 (en) * 1983-09-26 1985-05-02 Ortho Diagnostic Systems Inc. Sandwich hybridization method for nucleic acid detection
EP0159719B1 (en) * 1984-04-27 1993-06-30 Enzo Biochem, Inc. Hybridization method for the detection of genetic materials
WO1986003227A1 (en) * 1984-11-23 1986-06-05 Dgi, Inc. An assay for nucleic acid sequences, particularly genetic lesions
WO1986003782A1 (en) * 1984-12-19 1986-07-03 Blair Malcolm A D Improved sandwich hybridisation technique for the detection of nucleotide sequences
EP0192168A2 (en) * 1985-02-22 1986-08-27 Molecular Diagnostics, Inc. Solution-phase dual hybridization assay for detecting polynucleotide sequences
EP0198622A1 (en) * 1985-04-01 1986-10-22 Ecc International Limited Paper coating apparatus and method
EP0198662A1 (en) * 1985-04-12 1986-10-22 AMERSHAM INTERNATIONAL plc Method for nucleic acid hybridisation
WO1986007387A1 (en) * 1985-06-13 1986-12-18 Amgen Method and kit for performing nucleic acid hybridization assays
EP0238332A2 (en) * 1986-03-19 1987-09-23 Cetus Corporation Liquid hybridization method and kit for detecting the presence of nucleic acid sequences in samples
EP0238353A2 (en) * 1986-03-21 1987-09-23 ARS Holding 89 N.V. Methods of immunoassay

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0322311A3 (en) * 1987-12-21 1990-06-27 Applied Biosystems, Inc. Method and kit for detecting a nucleic acid sequence
EP0322311A2 (en) * 1987-12-21 1989-06-28 Applied Biosystems, Inc. Method and kit for detecting a nucleic acid sequence
US5354657A (en) * 1988-01-12 1994-10-11 Boehringer Mannheim Gmbh Process for the highly specific detection of nucleic acids in solid
GB2225112A (en) * 1988-11-22 1990-05-23 Ici Plc Hybridisation probes
US7060814B2 (en) 2000-03-31 2006-06-13 Sanko Junyaku Co., Ltd. Probe for constructing probe-polymer method of constructing probe-polymer and utilization thereof
WO2001075157A1 (fr) * 2000-03-31 2001-10-11 Sanko Junyaku Co., Ltd. Sonde servant a fabriquer un polymere sonde, procede de fabrication d'un polymere sonde et son utilisation
US8742101B2 (en) 2003-07-25 2014-06-03 Idenix Pharmaceuticals, Inc. Purine nucleoside analogues for treating flaviviridae including hepatitis C
US9186369B2 (en) 2003-07-25 2015-11-17 Idenix Pharmaceuticals, Llc Purine nucleoside analogues for treating flaviviridae including hepatitis C
WO2005071401A3 (en) * 2004-01-15 2005-12-01 Chiron Corp Homogeneous multiplex assay for nucleic acid targets
WO2005071401A2 (en) * 2004-01-15 2005-08-04 Chiron Corporation Homogeneous multiplex assay for nucleic acid targets
US9354176B2 (en) 2011-08-11 2016-05-31 Olympus Corporation Method for detecting a target particle
US9841418B2 (en) 2011-08-30 2017-12-12 Olympus Corporation Method for detecting target particle
US9428796B2 (en) 2012-02-22 2016-08-30 Olympus Corporation Method for detecting a target particle
EP2829614A1 (en) * 2012-03-21 2015-01-28 Olympus Corporation Method for detecting target nucleic acid molecule
EP2829614A4 (en) * 2012-03-21 2016-03-16 Olympus Corp METHOD FOR DETECTING A TARGET NUCLEIC ACID MOLECULE
US9771612B2 (en) 2012-03-21 2017-09-26 Olympus Corporation Method for detecting a target nucleic acid molecule

Also Published As

Publication number Publication date
CA1309932C (en) 1992-11-10
AU8103687A (en) 1988-05-06
FI882800A0 (fi) 1988-06-13
NO882593L (no) 1988-06-13
DK324088D0 (da) 1988-06-14
JPH01501339A (ja) 1989-05-11
FI882800A (fi) 1988-06-13
NO882593D0 (no) 1988-06-13
WO1988002785A3 (en) 1988-07-14

Similar Documents

Publication Publication Date Title
EP0828856B1 (en) Nucleic acid detection and amplification by chemical linkage of oligonucleotides
EP0070687B1 (en) Light-emitting polynucleotide hybridization diagnostic method
US6238866B1 (en) Detector for nucleic acid typing and methods of using the same
US6270974B1 (en) Exogenous nucleic acid detection
AU753273B2 (en) Mismatch detection techniques
CA1295535C (en) Rapid detection of nucleic acid sequences in a sample by labeling the sample
US6027877A (en) Use of immobilized mismatch binding protein for detection of mutations and polymorphisms, purification of amplified DNA samples and allele identification
JP2644215B2 (ja) 核酸配列、特に遺伝障害測定法
JP4494630B2 (ja) 中型縦列繰り返しdnaマーカーを特定し分析するための材料と方法
EP0204510B1 (en) Amplification of hybridization signals by employing complementary dna strands
EP0664339A1 (en) Method of discriminating nucleic acid and testing set for discriminating nucleic acid
JPH02503515A (ja) 標識された相補的核酸プローブを開裂する触媒反応の補因子としての活性に基づく核酸配列検出のための触媒ハイブリッド形成系
EP0407789B1 (en) Nucleic acid detection method
JPH0591898A (ja) 制限増巾検定法
JPH0364119B2 (no)
US5747256A (en) Homogeneous DNA probe titration assay
CA1309932C (en) Nucleic acid hybridization technique and kit therefor
EP0648222B1 (en) Methods of single nucleotide primer extension to detect specific alleles and kits therefor
WO1987005334A1 (en) Nucleic acid detection using particle agglutination
EP0425217A2 (en) A hybridization assay for campylobacter rRNA
US6027879A (en) Detection and isolation of nucleic acid sequences using a bifunctional hybridization probe
KR920007664B1 (ko) 핵산의 정제, 증폭 및 검사방법
Wei et al. CRISPR/Cas13a-based single-nucleotide polymorphism detection for reliable determination of ABO blood group genotypes
KR20230087965A (ko) CRISPR-Cas 기반의 아프리카돼지열병 바이러스 검출용 조성물 및 이를 이용한 아프리카돼지열병 바이러스 검출방법
AU1523799A (en) Methods and compositions for detection of specific nucleotide sequences

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU DK FI JP NO

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE FR GB IT LU NL SE

WWE Wipo information: entry into national phase

Ref document number: 1987906970

Country of ref document: EP

Ref document number: 882800

Country of ref document: FI

AK Designated states

Kind code of ref document: A3

Designated state(s): AU DK FI JP NO

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE FR GB IT LU NL SE

WWW Wipo information: withdrawn in national office

Ref document number: 1987906970

Country of ref document: EP